Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederglobenewswire.com
GlobeNewswire - Industry News on Pharmaceuticals
Get the latest updates from GlobeNewswire - Industry News on Pharmaceuticals directly as they happen.
Follow now 112 followers
Latest posts
Last updated about 6 hours ago
AscellaHealth’s Patient-Focused Approach is Best-in-Class Model for Distribution of Rare Disease Therapies
about 6 hours ago
AscellaHealth’s Patient-Focused Approach is Best-in-Class Model for Distribution of Rare Disease Therapies
60 Degrees Pharmaceuticals Announces Pricing of Up to $10 Million Public Offering
about 7 hours ago
60 Degrees Pharma (SXTP) prices $5M public offering with potential $5M from...
Medera and University of Kansas Medical Center Announce First Patient Treated in Pioneering Gene Therapy Trial for Duchenne Muscular Dystrophy Associated Cardiomyopathy
about 8 hours ago
Landmark MUSIC-DMD Phase 1b trial represents first-in-human gene therapy approach for DMD-associated...
Plus Therapeutics Presents ReSPECT-LM Clinical Trial Results for REYOBIQ™ in Patients with Leptomeningeal Metastases
about 9 hours ago
Presentation by trial principal investigator at the 2025 SNO/ASCO CNS Metastases Conference
60 Degrees Pharmaceuticals Defines Potential Human Babesiosis Market Size for ARAKODA® (tafenoquine): Annual Max TAM, Sales of $245 Million; Cumulative through Patent Expiration, $1.1 Billion
about 9 hours ago
60 Degrees sets human babesiosis TAM for ARAKODA at $245M annually, $1.1B...
Aquestive Therapeutics Provides International Expansion Update for Anaphylm™ (epinephrine) Sublingual Film
about 9 hours ago
WARREN, N.J., July 15, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ...
Sanara MedTech Inc. Announces Launch of Tissue Health Plus Wound Care Provider Pilot Program
about 24 hours ago
Pilot program designed to provide real-world evidence in the use of Tissue...
60 Degrees Pharmaceuticals to Submit MUMS (Minor Use/Minor Species) Designation Request to FDA for Tafenoquine for Acute Canine Babesiosis in 2025
1 day ago
60 Degrees to seek FDA MUMS designation for tafenoquine in canine babesiosis...
New 3-Year Phase 3 Data Confirmed Sustained Response to TransCon® PTH (Palopegteriparatide) Therapy in Adults with Hypoparathyroidism, Including Improvements in Biochemistries, Kidney Function, and Quality of Life
1 day ago
COPENHAGEN, Denmark, July 14, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq...
Ascentage Pharma Announces Pricing of Top-Up Placement
1 day ago
ROCKVILLE, Md. and SUZHOU, China, July 14, 2025 (GLOBE NEWSWIRE) -- Ascentage...
BiomX Announces Successful Initiation of Phase 2b Trial with First Patient Dosed in BX004 Program in Patients with Cystic Fibrosis
1 day ago
First patient dosing in Company’s Phase 2b trial marks pivotal milestone in...
Pineapple, Inc. to Launch Real-World Asset Token Designed to Monetize Intellectual Property
1 day ago
Tokenized IP platform built to enable access, utility, and engagement with Pineapple...